HKEX:601 stock news
This page provides real-time market news, earnings updates, and company announcements related to Rare Earth Magnesium Technology Group Holdings Limited (HKEX:601).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-23 22:52 HKT
‘Questions regarding the AI revolution are starting to surface,’ BofA reports, as investors view it as a ‘two-sided blade’ that might ‘undermine’ you
101 finance2026-02-20 19:24:31
Universal Display (OLED) Stock Trades Down, Here Is Why
Finviz2026-02-20 20:57:41
Why Is Sleep Number (SNBR) Stock Soaring Today
Finviz2026-02-20 20:57:43
Why JFrog (FROG) Stock Is Falling Today
Finviz2026-02-20 21:21:07
International rating agency Moody's has announced that it has revised Amazon's credit rating outlook from positive to stable.
老虎证券2026-02-20 21:52:07
JPMorgan Accelerates $1.5 Trillion Investment Plan: Wall Street Strategic Funds Flow into Key US Industries such as AI, Rare Earths, and Quantum Technology
金融界2026-02-21 05:10:41
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating
Finviz2026-02-21 11:33:23
If the latest disruptions in AI and cryptocurrency have left you unsettled, you may be focusing on the wrong trend
101 finance2026-02-21 14:57:11
Phillip Securities Cuts Palantir (PLTR) Target, Reiterates Buy Rating Again
Finviz2026-02-22 15:27:38
Blackstone Inc. (BX): A Bull Case Theory
Finviz2026-02-22 23:58:24
Blue Owl's Anxiety Sends Ripples Through the $1.8 Trillion Private Lending Sector
101 finance2026-02-23 00:21:15
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate
Finviz2026-02-23 02:27:10
How the AI Debt Frenzy Shattered the "Invisible Contract" Between Supercomputing Giants and Investors
新浪财经2026-02-23 10:31:56
Demand for downside protection hits four-year high, Goldman Sachs traders: Professional investors are preparing for "some kind of breakout"
华尔街见闻2026-02-23 11:28:55
1 of Wall Street’s Top Picks Added to Our Buy List, Plus 2 We Decided to Pass On
101 finance2026-02-23 11:27:34
1 Overlooked Stock Worth Revisiting and 2 Opportunities We Declined
101 finance2026-02-23 11:27:35
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Finviz2026-02-23 12:03:46
Atlas Critical Minerals Appoints Chief Technical Officer with Proven Track Record Across Multiple Critical Minerals
Finviz2026-02-23 12:03:47
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Finviz2026-02-23 12:33:46
Gossamer Bio Inc. (Ticker: GOSS) recently disclosed the topline data from its Phase III clinical trial, the Prosera study.
老虎证券2026-02-23 13:28:12
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Finviz2026-02-23 13:34:18
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Finviz2026-02-23 13:34:20
Flywire Appoints Patrick Blanc as Chief Technology Officer
Finviz2026-02-23 14:03:46
BitMine stock forms a rare bullish pattern as short interest hits 6%
Crypto.News2026-02-23 14:42:19
International rating agency Moody's has announced that it has revised Amazon's credit rating outlook from positive to stable.
老虎证券2026-02-20 21:52:07
JPMorgan Accelerates $1.5 Trillion Investment Plan: Wall Street Strategic Funds Flow into Key US Industries such as AI, Rare Earths, and Quantum Technology
金融界2026-02-21 05:10:41
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating
Finviz2026-02-21 11:33:23
If the latest disruptions in AI and cryptocurrency have left you unsettled, you may be focusing on the wrong trend
101 finance2026-02-21 14:57:11
Phillip Securities Cuts Palantir (PLTR) Target, Reiterates Buy Rating Again
Finviz2026-02-22 15:27:38
Blackstone Inc. (BX): A Bull Case Theory
Finviz2026-02-22 23:58:24
Blue Owl's Anxiety Sends Ripples Through the $1.8 Trillion Private Lending Sector
101 finance2026-02-23 00:21:15
Barclays Begins Amgen (AMGN) Coverage, Notes Balanced Outlook Despite Trial Debate
Finviz2026-02-23 02:27:10
How the AI Debt Frenzy Shattered the "Invisible Contract" Between Supercomputing Giants and Investors
新浪财经2026-02-23 10:31:56
Demand for downside protection hits four-year high, Goldman Sachs traders: Professional investors are preparing for "some kind of breakout"
华尔街见闻2026-02-23 11:28:55
1 of Wall Street’s Top Picks Added to Our Buy List, Plus 2 We Decided to Pass On
101 finance2026-02-23 11:27:34
1 Overlooked Stock Worth Revisiting and 2 Opportunities We Declined
101 finance2026-02-23 11:27:35
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Finviz2026-02-23 12:03:46
Atlas Critical Minerals Appoints Chief Technical Officer with Proven Track Record Across Multiple Critical Minerals
Finviz2026-02-23 12:03:47
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Finviz2026-02-23 12:33:46
Gossamer Bio Inc. (Ticker: GOSS) recently disclosed the topline data from its Phase III clinical trial, the Prosera study.
老虎证券2026-02-23 13:28:12
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Finviz2026-02-23 13:34:18
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Finviz2026-02-23 13:34:20
Flywire Appoints Patrick Blanc as Chief Technology Officer
Finviz2026-02-23 14:03:46
BitMine stock forms a rare bullish pattern as short interest hits 6%
Crypto.News2026-02-23 14:42:19
HKEX:601 stock price change
On the last trading day, HKEX:601 stock closed at 0.09 HKD, with a price change of 1.14% for the day.
Trade stock futuresHKEX:601 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more